Disaster Lit: Resource Guide for Disaster Medicine and Public Health 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.Fact Sheet for Healthcare Providers: EUROIMMUN Anti-SARS-CoV-2 ELISA (IgG)
Source: U.S. Food and Drug Administration (FDA). Published: 5/4/2020.
This three-page fact sheet informs healthcare providers of the significant known and potential risks and benefits of the emergency use of the EUROIMMUN Anti-SARS-CoV-2 ELISA (IgG), which received an Emergency Use Authorization from the Food and Drug Administration on May 4, 2020. The EUROIMMUN Anti-SARS-CoV-2 ELISA (IgG) is authorized for the detection of IgG antibodies to SARS-CoV-2 in human serum and plasma (K+-EDTA, Li+-heparin, Na+-citrate).
(PDF) (Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health)
Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health - May 4, 2020 Category: International Medicine & Public Health Source Type: news
Policy for Diagnostic Tests for Coronavirus Disease-2019 During the Public Health Emergency (Revised): Immediately in Effect Guidance for Clinical Laboratories, Commercial Manufacturers, and Food and Drug Administration Staff
Source: U.S. Food and Drug Administration (FDA). Published: 5/4/2020.
This 41-page guidance, updated on May 4, 2020, provides a policy to help accelerate the availability of novel coronavirus (COVID-19) tests developed by laboratories and commercial manufacturers for the duration of the public health emergency.
(PDF) (Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health)
Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health - May 4, 2020 Category: International Medicine & Public Health Source Type: news
Interim Infection Prevention and Control Guidance for Veterinary Clinics Treating Companion Animals During the COVID-19 Response
Source: Centers for Disease Control and Prevention, Office of Infectious Diseases (CDC OID). Published: 5/3/2020.
This interim guidance is for veterinarians and their staff who may be treating or advising on companion animal medical care during the COVID-19 pandemic. Veterinary facilities have unique characteristics that warrant unique infection control considerations.
(Text) (Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health)
Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health - May 3, 2020 Category: International Medicine & Public Health Source Type: news
Discontinuation of Isolation for Persons with COVID-19 Not in Healthcare Settings
Source: Centers for Disease Control and Prevention, Office of Infectious Diseases (CDC OID). Published: 5/3/2020.
This guidance, updated on May 3, 2020, is for healthcare providers and public health officials managing persons with coronavirus disease 2019 (COVID-19) under isolation who are not in healthcare settings. This includes, but is not limited to, at home, in a hotel or dormitory room, or in a group isolation facility.
(Text) (Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health)
Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health - May 3, 2020 Category: International Medicine & Public Health Source Type: news
Symptom-Based Strategy to Discontinue Isolation for Persons with COVID-19
Source: Centers for Disease Control and Prevention, Office of Infectious Diseases (CDC OID). Published: 5/3/2020.
This guidance, updated on May 3, 2020, details how in the context of COVID-19 community transmission where continued testing is impractical, available evidence at this time indicates that an interim strategy based on time-since-illness-onset and time-since-recovery can be implemented to establish the end of isolation.
(Text) (Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health)
Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health - May 3, 2020 Category: International Medicine & Public Health Source Type: news
Fact Sheet for Healthcare Providers: Elecsys Anti-SARS-CoV-2; Roche Diagnostics
Source: U.S. Food and Drug Administration (FDA). Published: 5/2/2020.
This three-page fact sheet informs healthcare providers of the significant known and potential risks and benefits of the emergency use of the Elecsys Anti- SARS-CoV-2 immunoassay, which received an Emergency Use Authorization from the Food and Drug Administration on May 2, 2020. The Elecsys Anti-SARS-CoV-2 immunoassay is authorized for the detection of antibodies to SARS-CoV-2 in human serum or plasma.
(PDF) (Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health)
Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health - May 2, 2020 Category: International Medicine & Public Health Source Type: news
Contact Tracing Workforce Estimator
Source: George Washington University (GWU). Published: 5/2020.
This tool is for state and local leaders to prepare for COVID-19 contact tracing in order to safely reopen and protect the health of communities. It uses a baseline of 15 contact tracers per 100,000 population and increases the number of contact tracers, as needed, to contact trace the 14-day number of new COVID-19 cases for each county over the course of a week.
(Text) (Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health)
Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health - May 1, 2020 Category: International Medicine & Public Health Source Type: news
CDC Interim Guidance for General Population Disaster Shelters During the COVID-19 Pandemic
Source: Centers for Disease Control and Prevention (CDC). Published: 5/2020.
This nine-page document provides interim guidance to reduce the risk of introducing and transmitting COVID-19 in general population disaster shelters before, during, or after a disaster. It should be used in conjunction with existing shelter operation and management plans, procedures, guidance, resources, and systems, and is not a substitute for shelter planning and preparedness activities.
(PDF) (Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health)
Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health - May 1, 2020 Category: International Medicine & Public Health Source Type: news
Health Departments: Interim Guidance on Developing a COVID-19 Case Investigation and Contact Tracing Plan
Source: Centers for Disease Control and Prevention (CDC). Published: 5/2020.
This 56-page guidance aims to provide a foundation for state, territorial, local, and tribal development of COVID-19 case investigation and contact tracing plans. It is important to note that COVID-19 case investigation and contact tracing activities will vary based on the level of community transmission, characteristics of the community and their populations, and the local capacity to implement case investigation, contact tracing, and COVID-19 testing.
(PDF) (Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health)
Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health - May 1, 2020 Category: International Medicine & Public Health Source Type: news
Toolkit on State Actions to Mitigate COVID-19 Prevalence in Nursing Homes
Source: Centers for Medicare& Medicaid Services (CMS). Published: 5/2020.
This 74-page toolkit catalogs the many innovative solutions designed at the state level to protect the nation ’s vulnerable nursing home residents during the coronavirus disease 2019 (COVID-19) pandemic. Major categories within the tables include: State Actions for COVID Management and Response; Telehealth; and Organizations that Are Available to Assist Nursing Homes.
(PDF) (Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health)
Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health - May 1, 2020 Category: International Medicine & Public Health Source Type: news
Supporting People with Addiction During COVID-19 Webinar Series: Landing Page
Source: National Academy of Medicine (NAM). Published: 5/2020.
This web page provides information and links to a webinar series from the National Academy of Medicine and the American Society of Addiction Medicine that provides insight and targeted guidance on how to ensure that individuals experiencing addiction are cared for and protected during the COVID-19 pandemic.
(Video or Multimedia) (Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health)
Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health - May 1, 2020 Category: International Medicine & Public Health Source Type: news
What You Need to Know About COVID-19 and the Role of Community Health Workers in the Latino Community
Source: Centers for Disease Control and Prevention (CDC). Published: 5/1/2020.
This one-hour webinar, held in English and Spanish, walks through what community health workers need to know about COVID-19 and their roles in the communities they serve during the emergency response efforts. Presenters discuss myths and rumors about COVID-19, cultural aspects for the prevention and treatment of the virus in the community, and CDC resources. The webinar was a collaboration with one of the CDC Emergency Partners Information Connection (EPIC) Partners, the National Association of Community Health Workers.
(Video or Multimedia) (S...
Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health - May 1, 2020 Category: International Medicine & Public Health Source Type: news
COVID-19 Technical Guidance: Providing Care for Children with Acute Respiratory Infections
Source: World Health Organization, Regional Office for Europe. Published: 5/2020.
The World Health Organization has developed some guidelines, materials, and apps on this web page that frontline healthcare providers may find useful when providing care for children with severe acute respiratory infections when COVID-19 is suspected. The WHO Pocket Book of Hospital Care for Children is available in several languages, including Armenian, Kazakh, Kyrgyz, Romanian, Russian, and Uzbek. Special attention is drawn to these sections, which are particularly relevant within the COVID-19 context: Chapter 4: information on cough and d...
Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health - May 1, 2020 Category: International Medicine & Public Health Source Type: news
Planning Hospital Needs for Ventilators and Respiratory Therapists in the COVID-19 Crisis
Source: RAND Corporation. Published: 5/2020.
To address the ventilator allocation problem during the COVID-19 pandemic, the authors of this 16-page report designed a model that can be used to calculate the number of ventilators and respiratory therapists needed to achieve a target wait time — the average delay for a ventilator experienced by a new patient. The target wait time corresponds with a probability that any wait is experienced: If the average wait is small, most patients would in fact experience no wait at all.
(PDF) (Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health)
Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health - May 1, 2020 Category: International Medicine & Public Health Source Type: news
Novel Coronavirus (COVID-19): Answers to Frequently Asked Questions
Source: Food and Agriculture Organization of the United Nations (FAO). Published: 5/2020.
This web page provides answers to frequently asked questions about the impact of the COVID-19 pandemic on food and agriculture, food safety, and fisheries and aquaculture.
(Text) (Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health)
Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health - May 1, 2020 Category: International Medicine & Public Health Source Type: news
